Важность:                           Высокая

 


Adis

Adis journals now part of Springer

Visit us at springer.com

Dear Customer,

Adis journals now part of Springer

We would like to inform you about our recent acquisition of Adis (as part of a larger acquisition of the Wolters Kluwers Pharma Marketing and Publishing Services division (MPS)). Adis was founded in the late 1960’s and became part of Wolters Kluwer in the mid 1990’s. The Adis offering consists of 24 journals and newsletters and 3 databases.

The Adis Journals

Adis publishes 24 highly-regarded scientific journals and newsletters specializing in pharmacology and pharmacotherapy. The journals offer independent, high-quality content with enviable impact factors and cover the following areas: Drug development, Pharmacoeconomics, Drug safety, Medical biotechnology and Disease management.

The flagship title Drugs, with an impact factor of 3.738, has been the definitive journal of drugs and therapeutics for over 40 years. Other key titles include Sports Medicine, impact factor 5.072; and Clinical Pharmacokinetics, impact factor 4.513.

For a complete overview of journals visit the Adis website.

The Adis journals will join the Springer pricelist for 2013 (available in August).

We think the Adis high-quality content and services form a perfect complement to our existing portfolio. In case you have any questions or would like to know more about the Adis products, please don’t hesitate to contact me or your
Springer sales representative.

Kind regards,

Leon Bolivar
Library Marketing Manager
Springer

Share this newsletter:

Share this with your Twitter followers

Post this on Facebook

Share this on LinkedIn

ADIS

Visit the Adis website!

Adis Connect 2012

Download the actual Product Brochure - Adis Connect 2012

separating line